Research Assistant on Behavioural Neurosciences and Model Organisms (PPCC- ADGUT_3)
Ref: PPCC- ADGUT_3 // Deadline: 25/02/2024
Search Results for:
Researcher in Microbiota-Gut-Brain Axis and Alzheimer’s diseases assessment.(PPCC- ADGUT_2)
Ref: PPCC- ADGUT_2 // Deadline: 25/02/2024
Research Assistant in Microbiota-Gut-Brain Axis and Alzheimer’s diseases assessment (PPCC- ADGUT_1)
Ref: PPCC- ADGUT_1 // Deadline: 25/02/2024
Postdoctoral position at the Research Group Microenvironments for Medicine (PD1-MS)
Ref: PD1-MS // Deadline 08/03/2024
Postdoctoral position at the Research Group Microenvironments for Medicine (PD2_MS)
Ref PD2_MS // Deadline: 08/03/2024
IBEC joins Spanish state consortium CERTERA to promote advanced therapies
The Institute for Bioengineering of Catalonia (IBEC) has recently joined CERTERA, the State Network Consortium for the Development of Advanced Therapy Medicines. IBEC has received funding for service provision, focusing specifically on the design and execution of early-stage clinical trials.
Nanomedicine experts gather on World Cancer Nanoday
Once again, experts in nanomedicine from various fields gathered in Barcelona on the occasion of World Cancer Day. The meeting provided an opportunity to showcase the latest innovations in nanomedicine for combating cancer, covering topics such as early diagnosis, controlled drug release, and radiotherapy employing nanoparticles.
New Methodology for Studying Organic Transistors in Operation with Applications in Bioelectronics
A study led by IBEC has successfully mapped the local electrical potential along the structure of organic transistors used in bioelectronics, enabling a detailed assessment of bottlenecks in charge transport. The goal of this study is to deepen the understanding of the properties of charge transport in materials used in organic electronics when in contact with liquid media, aiming to enhance their applications in biosensors or bioelectrical recordings.
IBEC is strengthened by the addition of three new research groups in advanced and emerging therapies
IBEC kicks off 2024 with the incorporation of three new research groups led by Manuel Salmerón Sánchez, Zaida Álvarez Pinto, and Xavier Rovira Clavé. With these additions, IBEC strengthens its position in the field of advanced and emerging therapies.